Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumors
-
Published:2024-09
Issue:
Volume:47
Page:102045
-
ISSN:1936-5233
-
Container-title:Translational Oncology
-
language:en
-
Short-container-title:Translational Oncology
Author:
Quinn Colin H.ORCID,
Beierle Andee M.,
Williams Adele P.,
Marayati Raoud,
Bownes Laura V.,
Market Hooper R.ORCID,
Erwin Michael E.ORCID,
Aye Jamie M.ORCID,
Stewart Jerry E.,
Mroczek-Musulman Elizabeth,
Yoon Karina J.,
Beierle Elizabeth A.